UnitedHealth Group Incorporated (NYSE:UNH) Holdings Raised by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 43,901 shares of the healthcare conglomerate’s stock after purchasing an additional 116 shares during the quarter. UnitedHealth Group comprises about 0.7% of Dana Investment Advisors Inc.’s investment portfolio, making the stock its 26th largest holding. Dana Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $22,208,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter worth about $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $37,000. Legacy Investment Solutions LLC acquired a new stake in UnitedHealth Group in the 3rd quarter worth approximately $57,000. Finally, DecisionPoint Financial LLC lifted its holdings in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $476.22 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $438.25 billion, a price-to-earnings ratio of 30.72, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The business’s fifty day moving average price is $514.58 and its two-hundred day moving average price is $554.81. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.83 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.76%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities research analysts recently weighed in on UNH shares. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, KeyCorp restated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.